Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Effects of the folk medicinal plant extract Ankaferd Blood Stopper® on the ocular surface.

Alpay A, Evren C, Bektaş S, Ugurbas SC, Ugurbas SH, Cınar F.

Cutan Ocul Toxicol. 2011 Dec;30(4):280-5. doi: 10.3109/15569527.2011.565011. Epub 2011 Mar 22.

PMID:
21425951
2.

Effects of a new hemostatic agent Ankaferd Blood Stopper(®)on the intraocular tissues in rat model.

Alpay A, Bektas S, Alpay A, Ugurbas SC, Evren C, Ugurbas SH.

Cutan Ocul Toxicol. 2012 Jun;31(2):128-31. doi: 10.3109/15569527.2011.627577. Epub 2011 Oct 28.

PMID:
22034855
3.

Use of a novel haemostatic agent: ankaferd blood stopper in conjunctival incisions.

Alpay A, Ugurbas SC, Evren C, Bektas S, Calıskan S, Ugurbas SH.

Clin Exp Ophthalmol. 2011 Nov;39(8):793-8. doi: 10.1111/j.1442-9071.2011.02578.x. Epub 2011 Jun 14.

PMID:
21631678
4.

Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, Ankaferd Blood Stopper, on vascular tissue in a rat aortic bleeding model.

Kandemir O, Buyukates M, Kandemir NO, Aktunc E, Gul AE, Gul S, Turan SA.

J Cardiothorac Surg. 2010 Nov 14;5:110. doi: 10.1186/1749-8090-5-110.

5.

New tools for the evaluation of toxic ocular surface changes in the rat.

Pauly A, Brignole-Baudouin F, Labbé A, Liang H, Warnet JM, Baudouin C.

Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5473-83.

PMID:
18055795
6.

Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model.

Tokgöz H, Karakaya K, Hanci V, Abduşoğlu M, Erol B, Türksoy O, Akduman B, Mungan NA.

Urology. 2010 Jun;75(6):1515.e9-14. doi: 10.1016/j.urology.2009.12.016. Epub 2010 Mar 12.

PMID:
20223504
7.

In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin.

Cipil HS, Kosar A, Kaya A, Uz B, Haznedaroglu IC, Goker H, Ozdemir O, Koroglu M, Kirazli S, Firat HC.

Clin Appl Thromb Hemost. 2009 May-Jun;15(3):270-6. doi: 10.1177/1076029608329578.

PMID:
19117967
8.

Evaluation of a new hemostatic agent Ankaferd Blood Stopper in experimental liver laceration.

Karakaya K, Ucan HB, Tascilar O, Emre AU, Cakmak GK, Irkorucu O, Ankarali H, Comert M.

J Invest Surg. 2009 May-Jun;22(3):201-6. doi: 10.1080/08941930902866246.

PMID:
19466658
9.

The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.

Kosar A, Cipil HS, Kaya A, Uz B, Haznedaroglu IC, Goker H, Ozdemir O, Ercetin S, Kirazli S, Firat HC.

Blood Coagul Fibrinolysis. 2009 Apr;20(3):185-90. doi: 10.1097/MBC.0b013e32831c4cb0.

PMID:
19657315
10.

[Comparison of the hemostatic efficiency of Ankaferd Blood Stopper and fibrin glue on a liver laceration model in rats].

Akarsu C, Kalaycı MU, Yavuz E, Ozkara S, Gökçek B, Ozdenkaya Y, Yalçın O.

Ulus Travma Acil Cerrahi Derg. 2011 Jul;17(4):308-12. Turkish.

11.

Evaluation of the hemostatic and histopathological effects of Ankaferd Blood Stopper in experimental liver injury in rats.

Satar NY, Akkoc A, Oktay A, Topal A, Inan K.

Blood Coagul Fibrinolysis. 2013 Jul;24(5):518-24. doi: 10.1097/MBC.0b013e32835e9498.

PMID:
23399904
12.

Hemostatic efficacy of a traditional medicinal plant extract (Ankaferd Blood Stopper) in bleeding control.

Sogut O, Erdogan MO, Kose R, Boleken ME, Kaya H, Gokdemir MT, Ozgonul A, Iynen I, Albayrak L, Dokuzoglu MA.

Clin Appl Thromb Hemost. 2015 May;21(4):348-53. doi: 10.1177/1076029613504129. Epub 2013 Sep 19.

PMID:
24057394
13.

Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models.

Abdelkader H, Ismail S, Hussein A, Wu Z, Al-Kassas R, Alany RG.

Int J Pharm. 2012 Aug 1;432(1-2):1-10. doi: 10.1016/j.ijpharm.2012.04.063. Epub 2012 Apr 30.

PMID:
22575752
14.

Beneficial effects of Ankaferd Blood Stopper on dermal wound healing: an experimental study.

Akalin C, Kuru S, Barlas AM, Kismet K, Kaptanoglu B, Demir A, Astarci HM, Ustun H, Ertas E.

Int Wound J. 2014 Feb;11(1):64-8. doi: 10.1111/j.1742-481X.2012.01063.x. Epub 2012 Sep 3.

PMID:
22943603
15.

The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects.

Yen MT, Pflugfelder SC, Feuer WJ.

Am J Ophthalmol. 2001 Mar;131(3):314-23.

PMID:
11239863
16.

Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface.

Becquet F, Goldschild M, Moldovan MS, Ettaiche M, Gastaud P, Baudouin C.

Curr Eye Res. 1998 Apr;17(4):419-25.

PMID:
9561834
17.

Differences in ocular surface irritation between timolol hemihydrate and timolol maleate.

Stewart WC, Stewart JA, Holmes KT, Leech JN.

Am J Ophthalmol. 2000 Dec;130(6):712-6.

PMID:
11124288
18.
19.

Medicinal plant extract (Ankaferd Blood Stopper) application in deep tissue injuries in rats: histopathological investigation of the effect on regional and systemic tissues.

Okumuş M, Yüksel KZ, Özbağ D, Çıralık H, Yılmaz Z, Gümüşalan Y, Bakan V, Kalender AM.

Ulus Travma Acil Cerrahi Derg. 2013 Jan;19(1):1-7. doi: 10.5505/tjtes.2013.65642.

20.

The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model.

Iynen I, Sogut O, Kose R.

Otolaryngol Head Neck Surg. 2011 Nov;145(5):840-4. doi: 10.1177/0194599811415594. Epub 2011 Jul 12.

PMID:
21750339

Supplemental Content

Support Center